500彩票网

We will draw upon the strengths and features of the Institute of Medical Science, the University of Tokyo (IMSUT), which conducts exceptional research and provides high-quality training in the field of infectious diseases to promote research activities and human resources development. To this end, we are establishing this matrix-type collaborative research platform for infectious disease control. The research platform includes: (i) Research Organizations for Infectious Diseases in the University of Tokyo, including the Department of Microbiology and Immunology, the International Research Center for Infectious Diseases, and the Research Center for Asian Infectious Diseases; (ii) the Alliance for Research Organization for Infectious Diseases in Japan, including the Research Center for Zoonosis Control (Hokkaido University), the Research Institute for Microbial Diseases (Osaka University), the Institute of Tropical Medicine (Nagasaki University), and IMSUT; and (iii) Overseas Research Centers including the Research Center for Asian Infectious Diseases (IMSUT), the University of Ghana, the Noguchi Memorial Institute for Medical Research (IMSUT), the University of Sierra Leone (IMSUT), the Hokudai Center for Zoonosis Control in Zambia, the Thailand-Japan Research Collaboration Center on Emerging and Re-emerging Infections (Osaka University), and the Vietnam Research Station (Nagasaki University). In addition to contributing to the establishment of this matrix-type collaborative research platform for infectious disease control, we will promote the development of preventive, diagnostic, and therapeutic methods for the control of infectious diseases as well as support the training of the next-generation of scientists in infectious disease research.

- Research Organization for Infectious Diseases, 500彩票网
- Research Center for Zoonosis Control, Hokkaido University
- Research Institute for Microbial Diseases, Osaka University
- Institute of Tropical Medicine, Nagasaki University

- [1] Marzi A, Halfmann P, Hill-Batorski L, Feldmann F, Shupert WL, Neumann G, Feldmann H, Kawaoka Y. An Ebola whole-virus vaccine is protective in nonhuman primates. Science 348:439-442, 2015.
- [2] Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, Takashita E, McBride R, Noda T, Hatta M, Imai H, Zhao D, Kishida N, Shirakura M, de Vries RP, Shichinohe S, Okamatsu M, Tamura T, Tomita Y, Fujimoto N, Goto K, Katsura H, Kawakami E, Ishikawa I, Watanabe S, Ito M, Sakai-Tagawa Y, Sugita Y, Uraki R, Yamaji R, Eisfeld AJ, Zhong G, Fan S, Ping J, Maher EA, Hanson A, Uchida Y, Saito T, Ozawa M, Neumann G, Kida H, Odagiri T, Paulson JC, Hasegawa H, Tashiro M, Kawaoka Y. Characterization of H7N9 influenza A viruses isolated from humans. Nature 501:551-555, 2013.
- [3] Sanada T, Kim M, Mimuro H, Suzuki M, Ogawa M, Oyama A, Ashida H, Kobayashi T, Koyama T, Nagai S, Shibata Y, Gohda J, Inoue J, Mizushima T, Sasakawa C. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. (2012) Nature. 483, 623-626.
- [4] Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. Experimental adaptation of an influenza H5 haemagglutinin confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428, 2012.
- [5] Arii J, Goto H, Suenaga T, Oyama M, Kozuka-Hata H, Imai T, Minowa A, Akashi H, Arase H, Kawaoka Y, Kawaguchi Y. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 467:859-862, 2010.